Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
10 pending office actions • 7 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Massachusetts Eye and Ear Infirmary currently manages 10 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are spread across 10 distinct examiners, meaning each examiner is responsible for exactly one pending matter. This one-to-one ratio between actions and examiners is notable for a portfolio of this size.
The portfolio spans 7 distinct art units, indicating a diverse range of technical subject matter within the medical devices field. FUBARA, BLESSING M is listed as the busiest examiner with 1 busiest examiner pending action. Since every examiner has only 1 pending action, the workload is balanced across the 10 distinct examiners currently engaged with the company's filings.
The presence of 7 distinct art units for 10 pending office actions suggests that while the technology area is consistent, the specific inventions are specialized. Practitioners must navigate a high number of individual examiner relationships across these 7 art units to maintain consistency in the Medical Devices & Mechanical Engineering sector.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (20%) |
| §112 only | 2 (20%) |
| Double-patenting + other | 1 (10%) |
| Multi-statute (no §101) | 5 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FUBARA, BLESSING M | 1 | 62.2% | +34.3% |
| ROY, BAISAKHI | 1 | 77.7% | +18.7% |
| WANG, CHANG YU | 1 | 33.5% | +53.5% |
| VIVLEMORE, TRACY ANN | 1 | 73.0% | +6.6% |
| BURKE, THOMAS P | 1 | 43.9% | +21.7% |
| ZAHORIK, AMANDA MARY | 1 | 57.8% | +49.0% |
| PARK, EVELYN GRACE | 1 | 51.6% | +40.5% |
| VIJAYARAGHAVAN, JAGAMYA NMN | 1 | 62.5% | +49.3% |
| SPENCER, ANDREA LYNNE MORRIS | 1 | 22.2% | +35.7% |
| KOHUTKA, BROOKE NICOLE | 1 | 37.5% | +92.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18284637 | SUBMUCOSAL IMPLANTABLE DRUG DELIVERY APPARATUSES, SYSTEMS, AND METHODS | BURKE, THOMAS P | 5d |
| 18595527 | AAV2-MEDIATED GENE DELIVERY OF SFASL AS A NEUROPROTECTIVE THERAPY IN GLAUCOMA | VIVLEMORE, TRACY ANN | — |
| 18258838 | SYSTEM FOR DIAGNOSIS OF AN OTITIS MEDIA VIA A PORTABLE DEVICE | PARK, EVELYN GRACE | — |
| 17920088 | HIGHLY-NETWORKED CORONAVIRUS IMMUNOGEN COMPOSITION | SPENCER, ANDREA LYNNE MORRIS | — |
| 17996715 | SYSTEMS AND METHODS FOR CONTROLLING THE SPREAD OF AIRBORNE MATERIALS DURING CLINICAL OR LABORATORY PROCEDURES | KOHUTKA, BROOKE NICOLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18275146 | METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS IN THE INNER EAR OF ADULT MAMMALS | ZAHORIK, AMANDA MARY | 24d overdue |
| 18835405 | AN ULTRA-FLEXIBLE MINIATURE OPTICAL COHERENCE TOMOGRAPHY CATHETER AND IMAGING METHOD FOR ENDOMICROSCOPY OF THE INNER EAR | ROY, BAISAKHI | 22d overdue |
| 18284637 | SUBMUCOSAL IMPLANTABLE DRUG DELIVERY APPARATUSES, SYSTEMS, AND METHODS | BURKE, THOMAS P | 5d |
| 18611374 | APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF | WANG, CHANG YU | 84d |
| 18825450 | Biodegradable Implant for Sustained Trans-Nasal Delivery of Therapeutic Agents to the Brain | FUBARA, BLESSING M | — |
| 18258838 | SYSTEM FOR DIAGNOSIS OF AN OTITIS MEDIA VIA A PORTABLE DEVICE | PARK, EVELYN GRACE | — |
| 17921971 | TARGETED BASE EDITING OF THE USH2A GENE | VIJAYARAGHAVAN, JAGAMYA NMN | — |
| 17920088 | HIGHLY-NETWORKED CORONAVIRUS IMMUNOGEN COMPOSITION | SPENCER, ANDREA LYNNE MORRIS | — |
| Art Unit | Apps |
|---|---|
| 3791 | 2 |
| 3797 | 1 |
| 1675 | 1 |
| 3741 | 1 |
| 1636 | 1 |
| 1633 | 1 |
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18825450 | Biodegradable Implant for Sustained Trans-Nasal Delivery of Therapeutic Agents to the Brain | FUBARA, BLESSING M | — | §102§103DP | Non-Final OA | — | Pending | Sep 05, 2024 |
| 18835405 | AN ULTRA-FLEXIBLE MINIATURE OPTICAL COHERENCE TOMOGRAPHY CATHETER AND IMAGING METHOD FOR ENDOMICROSCOPY OF THE INNER EAR | ROY, BAISAKHI | 3797 | §103 | Final Rejection | 22d overdue | Pending | Aug 02, 2024 |
| 18611374 | APOE ANTIBODIES, FUSION PROTEINS AND USES THEREOF | WANG, CHANG YU | 1675 | §112 | Non-Final OA | 84d | Pending | Mar 20, 2024 |
| 18595527 | AAV2-MEDIATED GENE DELIVERY OF SFASL AS A NEUROPROTECTIVE THERAPY IN GLAUCOMA | VIVLEMORE, TRACY ANN | — | §103§112 | Non-Final OA | — | Pending | Mar 05, 2024 |
| 18284637 | SUBMUCOSAL IMPLANTABLE DRUG DELIVERY APPARATUSES, SYSTEMS, AND METHODS | BURKE, THOMAS P | 3741 | §102§103 | Final Rejection | 5d | Pending | Sep 28, 2023 |
| 18275146 | METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS IN THE INNER EAR OF ADULT MAMMALS | ZAHORIK, AMANDA MARY | 1636 | §103 | Final Rejection | 24d overdue | Pending | Jul 31, 2023 |
| 18258838 | SYSTEM FOR DIAGNOSIS OF AN OTITIS MEDIA VIA A PORTABLE DEVICE | PARK, EVELYN GRACE | 3791 | §102§103 | Final Rejection | — | Pending | Jun 22, 2023 |
| 17921971 | TARGETED BASE EDITING OF THE USH2A GENE | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | §112 | Non-Final OA | — | Pending | Oct 27, 2022 |
| 17920088 | HIGHLY-NETWORKED CORONAVIRUS IMMUNOGEN COMPOSITION | SPENCER, ANDREA LYNNE MORRIS | 1631 | §102§103§112 | Non-Final OA | — | Pending | Oct 20, 2022 |
| 17996715 | SYSTEMS AND METHODS FOR CONTROLLING THE SPREAD OF AIRBORNE MATERIALS DURING CLINICAL OR LABORATORY PROCEDURES | KOHUTKA, BROOKE NICOLE | 3791 | §103§112 | Non-Final OA | — | Pending | Oct 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial